| scholarly article | Q13442814 |
| P50 | author | Ihor Batruch | Q130284117 |
| Eleftherios P. Diamandis | Q37383505 | ||
| Andrei Drabovich | Q50634266 | ||
| Theano Karakosta | Q63373394 | ||
| P2093 | author name string | Antoninus Soosaipillai | |
| P2860 | cites work | High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites | Q80651821 |
| Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4 | Q22010477 | ||
| Enzyme Immunoassay (EIA)/Enzyme-Linked Immunosorbent Assay (ELISA) | Q22306075 | ||
| A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum | Q24307894 | ||
| A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation | Q24324426 | ||
| A proteolytic cascade of kallikreins in the stratum corneum | Q24338337 | ||
| Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase | Q28209506 | ||
| Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones | Q28212939 | ||
| Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma | Q28215055 | ||
| Human tissue kallikreins: a family of new cancer biomarkers | Q28216059 | ||
| Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer | Q28254245 | ||
| The emerging roles of human tissue kallikreins in cancer | Q28290701 | ||
| Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression | Q28300449 | ||
| Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma | Q28302387 | ||
| The new human tissue kallikrein gene family: structure, function, and association to disease. | Q30328102 | ||
| Parallel overexpression of seven kallikrein genes in ovarian cancer. | Q30923845 | ||
| Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries | Q33207170 | ||
| Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins | Q33523589 | ||
| A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam | Q33558289 | ||
| An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers | Q33597992 | ||
| Expediting SRM assay development for large-scale targeted proteomics experiments | Q34286018 | ||
| Quality-of-life effects of prostate-specific antigen screening. | Q34294102 | ||
| Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics | Q34333925 | ||
| Quantification of human kallikrein-2 in clinical samples by selected reaction monitoring | Q34974503 | ||
| From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry | Q35044673 | ||
| Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay | Q35610622 | ||
| Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids | Q35692106 | ||
| Highly abundant defense proteins in human sweat as revealed by targeted proteomics and label-free quantification mass spectrometry. | Q36093839 | ||
| Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay | Q36144177 | ||
| Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins | Q36989604 | ||
| A human proteome detection and quantitation project | Q37210681 | ||
| Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer | Q37216583 | ||
| A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia | Q37289388 | ||
| Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells | Q37372273 | ||
| Functional roles of human kallikrein-related peptidases | Q37612613 | ||
| Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry | Q37687439 | ||
| LC-MS/MS for protein and peptide quantification in clinical chemistry | Q37946027 | ||
| Seminal plasma as a diagnostic fluid for male reproductive system disorders | Q38202841 | ||
| Toward an integrated pipeline for protein biomarker development | Q38248862 | ||
| ELISA in the multiplex era: potentials and pitfalls. | Q38341369 | ||
| Unleashing the therapeutic potential of human kallikrein-related serine proteases | Q38362486 | ||
| Proteomic analysis of human cervico-vaginal fluid | Q38516031 | ||
| Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer | Q40124703 | ||
| Vaginal odors and secretions. | Q40319655 | ||
| Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. | Q40344892 | ||
| Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids | Q40592208 | ||
| Human kallikrein 14: a new potential biomarker for ovarian and breast cancer | Q40604068 | ||
| Quantitative proteomics of the human skin secretome reveal a reduction in immune defense mediators in ectodermal dysplasia patients | Q41688112 | ||
| Neuropsin cleaves EphB2 in the amygdala to control anxiety | Q41962381 | ||
| Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids | Q44266903 | ||
| Genomic overview of serine proteases | Q44430552 | ||
| Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. | Q44521067 | ||
| Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids | Q46551494 | ||
| Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases | Q46640031 | ||
| Distribution of 15 human kallikreins in tissues and biological fluids | Q48134087 | ||
| Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility. | Q50873210 | ||
| Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. | Q50909231 | ||
| Structure of plasma and tissue kallikreins. | Q53116408 | ||
| The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease1 | Q56637802 | ||
| Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids | Q57941583 | ||
| Quantification of Eight Tissue Kallikreins in the Stratum Corneum and Sweat | Q57941944 | ||
| Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay | Q57942337 | ||
| Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications | Q57942965 | ||
| Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry | Q74523682 | ||
| Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera | Q78348094 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 2863-2876 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays | |
| P478 | volume | 15 |
| Q37591513 | A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9. |
| Q47374639 | Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. |
| Q57940294 | Discovery of a human testis-specific protein complex TEX101-DPEP3 and selection of its disrupting antibodies |
| Q63367449 | Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974 |
| Q38703356 | Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells |
| Q47660938 | Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy |
| Q47365249 | Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer |
| Q34553859 | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
| Q60937811 | The plasma peptides of ovarian cancer |
Search more.